Home › Compare › NVIVQ vs VICI

NVIVQ vs VICI: Dividend Comparison 2026

NVIVQ yields 540.54% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVIVQ wins by $112785.26M in total portfolio value
10 years
NVIVQ
NVIVQ
● Live price
540.54%
Share price
$0.37
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112786.22M
Annual income
$82,692,515,806.61
Full NVIVQ calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — NVIVQ vs VICI

📍 NVIVQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVIVQVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVIVQ + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NVIVQ pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVIVQ
Annual income on $10K today (after 15% tax)
$45,945.95/yr
After 10yr DRIP, annual income (after tax)
$70,288,638,435.62/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, NVIVQ beats the other by $70,288,122,165.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVIVQ + VICI for your $10,000?

NVIVQ: 50%VICI: 50%
100% VICI50/50100% NVIVQ
Portfolio after 10yr
$56393.60M
Annual income
$41,346,561,591.37/yr
Blended yield
73.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

NVIVQ
No analyst data
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVIVQ buys
0
VICI buys
0
No recent congressional trades found for NVIVQ or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVIVQVICI
Forward yield540.54% ✓6.52%
Annual dividend / share$2.00 ✓$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3% ✓
Portfolio after 10y$112786.22M ✓$966.2K
Annual income after 10y$82,692,515,806.61 ✓$607,376.13
Total dividends collected$110217.05M ✓$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NVIVQ vs VICI ($10,000, DRIP)

YearNVIVQ PortfolioNVIVQ Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$64,754$54,054.05$11,361$941.49+$53.4K → NVIVQ
2$396,410$327,123.28$13,320$1,481.32+$383.1K → NVIVQ
3$2,295,726$1,871,567.31$16,284$2,405.01+$2.28M → NVIVQ
4$12,586,137$10,129,710.14$21,040$4,071.78+$12.57M → NVIVQ
5$65,369,349$51,902,182.37$29,209$7,285.49+$65.34M → NVIVQ
6$321,877,325$251,932,121.38$44,443$14,006.51+$321.83M → NVIVQ
7$1,503,762,535$1,159,353,797.14$75,822$29,512.55+$1503.69M → NVIVQ
8$6,671,013,644$5,061,987,731.83$148,733$69,726.75+$6670.86M → NVIVQ
9$28,124,961,234$20,986,976,635.20$344,394$189,413.75+$28124.62M → NVIVQ
10$112,786,224,327$82,692,515,806.61$966,234$607,376.13+$112785.26M → NVIVQ

NVIVQ vs VICI: Complete Analysis 2026

NVIVQ — Stock

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Full NVIVQ Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this NVIVQ vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVIVQ vs SCHDNVIVQ vs JEPINVIVQ vs ONVIVQ vs KONVIVQ vs MAINNVIVQ vs NNNNVIVQ vs EPRTNVIVQ vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.